01243nam1 2200373 450 9900009510402033160095104USA010095104(ALEPH)000095104USA01009510420020207d--------km-y0itay0103----baengUS||||||||001yyCode of Federal regulationspublished by Office of the Federal register, National archives and Records administrations as a special edition of the Federal RegisterWashingtonNational Archives and Recordsv.24 cm2001001-------2001Diritto amministrativoStati Uniti d'America342.7306Stati Uniti d'America423514National archives and Records administrations : Office of the Federal registerITsalbcISBD990000951040203316VARIE 402LMVARIEBKUMAPATTY9020020207USA011314PATTY9020020207USA01132320020403USA011738PATRY9020040406USA011705Code of Federal regulations973172UNISA02746nam 2200613 450 991081003370332120230803021710.01-118-47334-51-118-47330-21-118-47337-X(CKB)2550000001115767(EBL)1376942(OCoLC)857969529(MiAaPQ)EBC1376942(DLC) 2013019255(Au-PeEL)EBL1376942(CaPaEBR)ebr10756810(CaONFJC)MIL516102(EXLCZ)99255000000111576720130506h20132013 uy| 0engur|n|---|||||rdacontentrdamediardacarrierBlood and marrow transplantation long-term management prevention and complications /edited by Bipin N. SavaniChichester, West Sussex, UK :John Wiley & Sons,[2013]©20131 online resource (416 p.)Description based upon print version of record.1-118-47340-X 1-299-84851-6 Includes bibliographical references and index.section 1. Late effects concepts -- section 2. Management -- section 3. Supportive care for long-term survivors after HSCT. Currently more than 100,000 patients undergo blood and marrow transplantation (BMT) annually worldwide, a number which is steadily increasing. Long-term survival after BMT has improved significantly since its inception over 40 years ago, due to improved supportive care and early recognition of long-term complications. With broadening indications, more options for BMT, and improvement in survival, by 2020 there may be up to a million long-term survivors after BMT globally. Higher than average rates of second malignancies and cardiopulmonary, infectious, endocrine, and renal diseases, and bonHematopoietic stem cellsTransplantationBone marrowTransplantationHematopoietic stem cellsTransplantationComplicationsBone marrowTransplantationComplicationsLong-term care of the sickHematopoietic stem cellsTransplantation.Bone marrowTransplantation.Hematopoietic stem cellsTransplantationComplications.Bone marrowTransplantationComplications.Long-term care of the sick.616.02/774Savani Bipin N1593635MiAaPQMiAaPQMiAaPQBOOK9910810033703321Blood and marrow transplantation long-term management3913863UNINA